185 related articles for article (PubMed ID: 31077532)
1. Health-related quality of life around the time of diagnosis in patients with bladder cancer.
Yu EY; Nekeman D; Billingham LJ; James ND; Cheng KK; Bryan RT; Wesselius A; Zeegers MP
BJU Int; 2019 Dec; 124(6):984-991. PubMed ID: 31077532
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life among non-muscle-invasive bladder cancer survivors: a population-based study.
Jung A; Nielsen ME; Crandell JL; Palmer MH; Smith SK; Bryant AL; Mayer DK
BJU Int; 2020 Jan; 125(1):38-48. PubMed ID: 31381249
[TBL] [Abstract][Full Text] [Related]
3. Recovery of health-related quality of life in patients undergoing robot-assisted radical cystectomy with intracorporeal diversion.
Abozaid M; Tan WS; Khetrapal P; Baker H; Duncan J; Sridhar A; Briggs T; Selim M; Abdallah MM; Elmahdy AA; Elserafy F; Kelly JD
BJU Int; 2022 Jan; 129(1):72-79. PubMed ID: 34092021
[TBL] [Abstract][Full Text] [Related]
4. Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer.
Blazeby JM; Hall E; Aaronson NK; Lloyd L; Waters R; Kelly JD; Fayers P
Eur Urol; 2014 Dec; 66(6):1148-56. PubMed ID: 24612661
[TBL] [Abstract][Full Text] [Related]
5. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract][Full Text] [Related]
6. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
[TBL] [Abstract][Full Text] [Related]
7. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
[TBL] [Abstract][Full Text] [Related]
8. Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
Ripping TM; Rammant E; Witjes JA; Aaronson NK; van Hemelrijck M; van Hoogstraten LMC; ; Kiemeney LA; Aben KKH
Health Qual Life Outcomes; 2022 Dec; 20(1):171. PubMed ID: 36581934
[TBL] [Abstract][Full Text] [Related]
9. Health-related Quality of Life During the First 4 Years After Non-Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort.
Beeren I; Klerks NE; Aben KK; Oddens JR; Witjes JA; Kiemeney LA; Vrieling A
Eur Urol Oncol; 2023 Nov; ():. PubMed ID: 37996278
[TBL] [Abstract][Full Text] [Related]
10. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
Sommer K; Cottone F; Aaronson NK; Fayers P; Fazi P; Rosti G; Angelucci E; Gaidano G; Venditti A; Voso MT; Baccarani M; Vignetti M; Efficace F
Qual Life Res; 2020 Mar; 29(3):815-823. PubMed ID: 31782016
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
12. Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies.
Efficace F; Cottone F; Sommer K; Kieffer J; Aaronson N; Fayers P; Groenvold M; Caocci G; Lo Coco F; Gaidano G; Niscola P; Baccarani M; Rosti G; Venditti A; Angelucci E; Fazi P; Vignetti M; Giesinger J
Value Health; 2019 Nov; 22(11):1303-1310. PubMed ID: 31708068
[TBL] [Abstract][Full Text] [Related]
13. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.
Gough N; Koffman J; Ross JR; Riley J; Judson I
PLoS One; 2019; 14(9):e0210731. PubMed ID: 31557183
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors.
Gacci M; Saleh O; Cai T; Gore JL; D'Elia C; Minervini A; Masieri L; Giannessi C; Lanciotti M; Varca V; Simonato A; Serni S; Carmignani G; Carini M
Health Qual Life Outcomes; 2013 Mar; 11():43. PubMed ID: 23497292
[TBL] [Abstract][Full Text] [Related]
15. Psychometric properties of the EORTC QLQ-C30 in Uganda.
Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
[TBL] [Abstract][Full Text] [Related]
16. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
Li Q; Lin Y; Qiu Y; Gao B; Xu Y
Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
[TBL] [Abstract][Full Text] [Related]
17. Exploring patients' experience and perception of being diagnosed with bladder cancer: a mixed-methods approach.
Tan WS; Teo CH; Chan D; Ang KM; Heinrich M; Feber A; Sarpong R; Williams N; Brew-Graves C; Ng CJ; Kelly J;
BJU Int; 2020 May; 125(5):669-678. PubMed ID: 31975539
[TBL] [Abstract][Full Text] [Related]
18. Reference data of the EORTC QLQ-C30 questionnaire: five consecutive annual assessments of approximately 2000 representative Dutch men and women.
Mols F; Husson O; Oudejans M; Vlooswijk C; Horevoorts N; van de Poll-Franse LV
Acta Oncol; 2018 Oct; 57(10):1381-1391. PubMed ID: 29912607
[TBL] [Abstract][Full Text] [Related]
19. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
20. Baseline Health-related Quality of Life Predicts Bladder Cancer-specific Survival Following Radical Cystectomy.
Westhofen T; Eismann L; Buchner A; Schlenker B; Giessen-Jung C; Becker A; Stief CG; Kretschmer A
Eur Urol Focus; 2022 Nov; 8(6):1659-1665. PubMed ID: 35184991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
